Pancreatic Islet Allo Transplantation

in Patients with Stable Kidney Graft Function

Funded Internally

Islet after Kidney Transplantation 

I am writing to let you know about an opportunity to participate in a research study designed for patients with Type 1 Diabetes who has already received a kidney transplant and kidney graft function has been stable. 

The study may benefit especially for those patients with challenging blood glucose control, high HA1c and those with hypoglycemic unawareness. 

This study is being conducted by myself, Dr. Piotr Witkowski at the University of Chicago.

This research study will assess the safety, tolerability and efficacy of the islet transplantation in patients with stable islet allograft function.

You may be eligible for this study if:

  • you are between the ages of 18-65,

  • you have stable kidney graft function

  • you have been diagnosed with Type 1 Diabetes

If you are interested in learning more about this study, contact our Clinical Study Manager Lindsay Basto, RN, BSN, or 773-702-2504, for more information.

It is important to know that this letter is not to tell you to join the study.

It is your decision, and your participation is voluntary.

Whether you show interest, and participate in the study or not, it will have no effect on your treatment with your doctors. 

Thank you for your interest and consideration, 


Piotr Witkowski M.D. Ph.D​​










Transplantation Institute

Clinical  Research Center


Islet and Kidney Transplantation

Manager, Lindsay Basto RN MSN

tel. (773) 702-2504

fax (773) 926-0671


Islet and Cell Processing and Research

Manager, Karolina Golab, PhD

Transplantation Institute

University of Chicago Medicine

5841 S. Maryland Avenue

MC 5026, J-517

Chicago IL 60637

Polish-American Transplant Center

Clinical Coordinator

Patrycja Ulijaszyk RN

  • Facebook - Grey Circle
  • Twitter - Grey Circle

© 2018 by Kajetan Witkowski